Related Experiment Video
Updated: Jan 18, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
An Effective Oral Drug Delivery Route for Pharmacokinetic Complications: Spirulina Lipid Nanotechnology System
Jiahui Ye1,2, Xinyi Wu3, Jin Liu3
1Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, P. R. China.
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder characterized by mental manifestations, abdominal pain, and alterations in defecation habits. The incidence rate in some areas even exceeds 20%. Secondary to chronic, recurrent gastrointestinal motility dysfunction, for patients with IBS, upon oral administration of drugs, the fluctuation of bioavailability is typically far more significant than that of healthy individuals. Nevertheless, at present, few studies have put forward targeted drug delivery systems addressing this aspect. In this study, an oral spirulina nanotechnology System (SP@TIIAn) is developed that integrates tanshinone IIA liposome with spirulina for enhanced IBS treatment. Owing to the passive targeting of intestinal villi and enhanced adhesion by spirulina and nanoparticles, it is discovered that, in contrast to enteric-coated capsules, this system is more beneficial for guaranteeing the pharmacokinetic stability of IBS. SP@TIIAn effectively treats multiple gut-brain symptoms of IBS, contributing to providing new alternatives for the development of clinical medications for IBS.
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder characterized by mental manifestations, abdominal pain, and alterations in defecation habits. The incidence rate in some areas even exceeds 20%. Secondary to chronic, recurrent gastrointestinal motility dysfunction, for patients with IBS, upon oral administration of drugs, the fluctuation of bioavailability is typically far more significant than that of healthy individuals. Nevertheless, at present, few studies have put forward targeted drug delivery systems addressing this aspect. In this study, an oral spirulina nanotechnology System (SP@TIIAn) is developed that integrates tanshinone IIA liposome with spirulina for enhanced IBS treatment. Owing to the passive targeting of intestinal villi and enhanced adhesion by spirulina and nanoparticles, it is discovered that, in contrast to enteric-coated capsules, this system is more beneficial for guaranteeing the pharmacokinetic stability of IBS. SP@TIIAn effectively treats multiple gut-brain symptoms of IBS, contributing to providing new alternatives for the development of clinical medications for IBS.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Enteral Route
Bioavailability Enhancement: Drug Permeability Enhancement
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...

